Longitude Capital Partners III, LLC - 10%+ Owner at Inozyme Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
INZY
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Longitude Capital Partners III, LLC since 12 Mar 2025

Holdings reported by Longitude Capital Partners III, LLC for Inozyme Pharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,174,379 $14,902,533 $3.57 19 Apr 2022 By Longitude Venture Partners III, L.P.

Transactions reported by Longitude Capital Partners III, LLC for Inozyme Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.